Sumitomo Mitsui Trust Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Buy |
|
|||||
|
2025
Q1 | $193M | Buy |
|
|||||
|
2024
Q4 | $216M | Buy |
|
|||||
|
2024
Q3 | $317M | Buy |
|
|||||
|
2024
Q2 | $313M | Sell |
|
|||||
|
2024
Q1 | $307M | Sell |
|
|||||
|
2023
Q4 | $280M | Sell |
|
|||||
|
2023
Q3 | $270M | Sell |
|
|||||
|
2023
Q2 | $240M | Sell |
|
|||||
|
2023
Q1 | $307M | Sell |
|
|||||
|
2022
Q4 | $274M | Sell |
|
|||||
|
2022
Q3 | $269M | Sell |
|
|||||
|
2022
Q2 | $236M | Sell |
|
|||||
|
2022
Q1 | $284M | Sell |
|
|||||
|
2021
Q4 | $273M | Sell |
|
|||||
|
2021
Q3 | $284M | Sell |
|
|||||
|
2021
Q2 | $308M | Buy |
|
|||||
|
2021
Q1 | $235M | Buy |
|
|||||
|
2020
Q4 | $217M | Sell |
|
|||||
|
2020
Q3 | $258M | Sell |
|
|||||
|
2020
Q2 | $301M | Buy |
|
|||||
|
2020
Q1 | $196M | Sell |
|
|||||
|
2019
Q4 | $175M | Sell |
|
|||||
|
2019
Q3 | $132M | Buy |
|
|||||
|
2019
Q2 | $137M | Buy |
|
|||||
|
2019
Q1 | $134M | Buy |
|
|||||
|
2018
Q4 | $110M | Buy |
|
|||||
|
2018
Q3 | $102M | Buy |
|
|||||
|
2018
Q2 | $85.3M | Buy |
|
|||||
|
2018
Q1 | $77M | Buy |
|
|||||
|
2017
Q4 | $82.6M | Buy |
|
|||||
|
2017
Q3 | $97M | Sell |
|
|||||
|
2017
Q2 | $108M | Buy |
|
|||||
|
2017
Q1 | $84M | Buy |
|
|||||
|
2016
Q4 | $79.3M | Buy |
|
|||||
|
2016
Q3 | $86.6M | Buy |
|
|||||
|
2016
Q2 | $75.1M | Buy |
|
|||||
|
2016
Q1 | $77.2M | Buy |
|
|||||
|
2015
Q4 | $113M | Sell |
|
|||||
|
2015
Q3 | $96.4M | Buy |
|
|||||
|
2015
Q2 | $104M | Sell |
|
|||||
|
2015
Q1 | $97.7M | Buy |
|
|||||
|
2014
Q4 | $76.8M | Sell |
|
|||||
|
2014
Q3 | $68.5M | Sell |
|
|||||
|
2014
Q2 | $53.7M | Sell |
|
|||||
|
2014
Q1 | $58.9M | Buy |
|
|||||
|
2013
Q4 | $54M | Sell |
|
|||||
|
2013
Q3 | $63.3M | Sell |
|
|||||
|
2013
Q2 | $45.8M | Buy |
|